Post a crumb
X

How Does Sanofi-GSK’s New COVID Vaccine Work? What’s Different?

The experimental vaccine is in the Phase 2 trial. Here’s what you need to know about it. French pharma giant Sanofi and UK's GlaxoSmithKline Plc (GSK) reported on Monday, 17 May, that the clinical trials of their COVID-19 vaccine showed strong immune response, as the world races to deliver vaccines to help end the pandemic. The vaccine candidate “achieved strong rates of neutralising antibody responses, in line with those measured in people who have recovered from COVID-19, in all adult age groups in a Phase 2 study with 722 volunteers," the companies said in a . This comes after a setback in December last year, when the companies said that the vaccine candidate failed to induce a strong enough immune response in people 50 years and older in the interim results. The companies had added that the vaccine would only be ready by the end of 2021. How does the vaccine work?........Read more

Comments